Cofounders
-
Eric Witze, PhD
Eric has worked to establish the regulation of cancer signaling pathways by palmitoylation and demonstrate the potential as a therapeutic target in cancer.
-
George Burslem, PhD
George works at the chemistry/biology interface with expertise extending from chemical biology, to medicinal chemistry and drug discovery.
-
Donita Brady, PhD
Donita utilizes biochemistry, cell biology, and in vivo mouse models to dissect the molecular regulation of signal transduction pathways in cancer.